ESSA Pharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ESSA Pharma Stock Summary

ESSA Pharma competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, RenovoRx, and Tempest Therapeutics. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Essa Pharma is traded on NASDAQ Exchange in the United States.

ESSA Pharma Key Financial Ratios

ESSA Pharma Key Balance Sheet Accounts

ESSA Pharma Key Income Statement Accounts

ESSA Pharma Key Cash Accounts

ESSA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ESSA Pharma's current stock value. Our valuation model uses many indicators to compare ESSA Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ESSA Pharma competition to find correlations between indicators driving ESSA Pharma's intrinsic value. More Info.ESSA Pharma is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . At this time, ESSA Pharma's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ESSA Pharma's earnings, one of the primary drivers of an investment's value.

ESSA Pharma Systematic Risk

Today, most investors in ESSA Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ESSA Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ESSA Pharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ESSA Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ESSA Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of ESSA Pharma based on widely used predictive technical indicators. In general, we focus on analyzing ESSA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ESSA Pharma's daily price indicators and compare them against related drivers.

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.